Minimal alteration of pulmonary function after lobectomy in lung cancer patients with chronic obstructive pulmonary disease  Yasuo Sekine, MD, Takekazu.

Slides:



Advertisements
Similar presentations
Curative Treatment of Stage I Non-Small-Cell Lung Cancer in Patients With Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review  David.
Advertisements

Transcatheter Aortic Valve Replacement Results in Improvement of Pulmonary Function in Patients With Severe Aortic Stenosis  Richard C. Gilmore, BA, Vinod.
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer 
The Society of Thoracic Surgeons Practice Guideline on the Prophylaxis and Management of Atrial Fibrillation Associated With General Thoracic Surgery:
Roland Assi, MD, MMS, Daniel J. Wong, MD, Daniel J. Boffa, MD, Frank C
Prediction of Long-Term Survival After Lung Cancer Surgery for Elderly Patients in The Society of Thoracic Surgeons General Thoracic Surgery Database 
Perioperative Lung Function Monitoring for Anatomic Lung Resections
Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer  Chenxi Zhong, MD, Wentao Fang, MD, Teng Mao,
B-Type Natriuretic Peptide as a Predictor of Postoperative Cardiopulmonary Complications in Elderly Patients Undergoing Pulmonary Resection for Lung Cancer 
Two years’ outcome of lung volume reduction surgery in different morphologic emphysema types  Jürg Hamacher, MD, Konrad E Bloch, MD, Uz Stammberger, MD,
Usefulness of Lung Perfusion Scintigraphy Before Lung Cancer Resection in Patients with Ventilatory Obstruction  Tommaso C. Mineo, MD, Orazio Schillaci,
Lung Volume Reduction Reoperations
Mortality Risk and Pulmonary Function in Adults With Cystic Fibrosis at Time of Wait Listing for Lung Transplantation  Don Hayes, MD, MS, Stephen Kirkby,
Vibration response imaging versus perfusion scan in lung cancer surgery evaluation  Nuria Marina, MD, Gema Rodriguez-Trigo, MD, Unai Jimenez, MD, Beatriz.
Prediction of Prognosis and Surgical Indications for Pulmonary Metastasectomy From Colorectal Cancer  Toshihiko Iizasa, MD, Makoto Suzuki, MD, Shigetoshi.
Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.
Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung  Kenzo Hiroshima, MD, Akira Iyoda, MD, Kiyoshi Shibuya, MD, Tetsuya.
David P. Mason, MD, Jeevanantham Rajeswaran, MS, Sudish C
Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis  Takekazu Iwata, MD, PhD, Shigetoshi Yoshida,
Impact of Lung Function Changes After Induction Radiochemotherapy on Resected T4 Non-Small Cell Lung Cancer Outcome  Jean Perentes, MD, PhD, Sabina Bopp,
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
Ki-67 expression and prognosis for smokers with resected stage i Non–Small cell lung cancer  Yukiko Haga, MD, Kenzo Hiroshima, MD, Akira Iyoda, MD, Kiyoshi.
Effect of modified ultrafiltration in high-risk patients undergoing operations for congenital heart disease1  Ko Bando, MD, Mark W Turrentine, MD, Palaniswamy.
Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,
Mark F. Berry, MD, Nestor R. Villamizar-Ortiz, MD, Betty C
Surgical Treatment of Metachronous Second Primary Lung Cancer
A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer  Brian C. Gulack, MD, Chi-Fu Jeffrey Yang,
Vibration Response Imaging in Prediction of Pulmonary Function After Pulmonary Resection  Hyun Koo Kim, MD, PhD, DaeGwang Yoo, MD, Ho Kyung Sung, MD,
Therapeutic Bronchoscopy Interventions Before Surgical Resection of Lung Cancer  Prashant N. Chhajed, MD, Ralf Eberhardt, MD, Hendrik Dienemann, MD, Andrea.
Intrapleural Instillation of Autologous Blood for Persistent Air Leak in Spontaneous Pneumothorax in Patients With Advanced Chronic Obstructive Pulmonary.
Characteristics Associated With the Use of Nonanatomic Resections Among Medicare Patients Undergoing Resections of Early-Stage Lung Cancer  Anthony W.
Pulmonary Function Tests Overestimate Chronic Pulmonary Disease in Patients With Severe Aortic Stenosis  Mitchell J. Magee, MD, Morley A. Herbert, PhD,
Management of Intersegmental Plane on Pulmonary Segmentectomy Concerning Postoperative Complications  Hajime Saito, MD, PhD, Hayato Konno, MD, PhD, Maiko.
Prospective Study on Functional Results After Lung-Sparing Radical Pleurectomy in the Management of Malignant Pleural Mesothelioma  Servet Bölükbas, MD,
Lobectomy improves ventilatory function in selected patients with severe COPD1  Robert J Korst, MD, Robert J Ginsberg, MD, Maneesh Ailawadi, MD, Manjit.
Survival and function after sleeve lobectomy for lung cancer
Segmentectomy for selected cT1N0M0 non–small cell lung cancer: A prospective study at a single institute  Hiroaki Nomori, PhD, Takeshi Mori, PhD, Koei.
Better pulmonary function and prognosis with video-assisted thoracic surgery than with thoracotomy  Shizuka Kaseda, MD, Teruhiro Aoki, MD, Nanae Hangai,
Outcomes and Costs for Major Lung Resection in the United States: Which Patients Benefit Most From High-Volume Referral?  Elliot Wakeam, MD, MPH, Joseph.
The evaluation of lymph node metastasis by endobronchial ultrasound-guided transbronchial needle aspiration: Crucial for selection of surgical candidates.
Relationship Between Functional Preservation after Segmentectomy and Volume- Reduction Effects after Lobectomy in Stage I Non-small Cell Lung Cancer Patients.
Pulmonary large cell neuroendocrine carcinoma demonstrates high proliferative activity  Akira Iyoda, MD, Kenzo Hiroshima, MD, Yasumitsu Moriya, MD, Teruaki.
Lung Function and ECMO After Lung Transplantation
Risk Factors for Developing Postthymectomy Myasthenia Gravis in Thymoma Patients  Yoshito Yamada, MD, PhD, Shigetoshi Yoshida, MD, PhD, Takekazu Iwata,
Pulmonary Resection for Lung Cancer in Octogenarians
Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer  Mark F. Berry, MD, Chi-Fu Jeffrey.
Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Differentiating N0 Versus N1 Lung Cancer  Kazuhiro Yasufuku, MD, PhD, Takahiro Nakajima,
Pattern of Metastasis Outside Tumor-Bearing Segments in Primary Lung Cancer: Rationale for Segmentectomy  Yuichi Sakairi, MD, PhD, Ichiro Yoshino, MD,
High Risk for Thoracotomy but not Thoracoscopic Lobectomy
Michael T. Durheim, MD, Sunghee Kim, PhD, Brian C
Compensation of pulmonary function after upper lobectomy versus lower lobectomy  Kazuhiro Ueda, MD, Toshiki Tanaka, MD, Masataro Hayashi, MD, Tao-Sheng.
Ko Bando, MD, Kyung Sun, MD, Robert S Binford, MD, Thomas G Sharp, MD 
Lymph Node Staging by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in Patients With Small Cell Lung Cancer  Hironobu Wada, MD, Takahiro.
Predicted Versus Observed FEV1 and Dlco After Major Lung Resection: A Prospective Evaluation at Different Postoperative Periods  Alessandro Brunelli,
Bilateral versus single lung transplantation for chronic obstructive pulmonary disease: intermediate-term results  Alberto Pochettino, MD, Robert M Kotloff,
Scatter plot of body mass index (BMI) versus forced expiratory volume in the first second (FEV1), and linear correlation lines for normal spirometry and.
Neal S Goldstein, MD  The Annals of Thoracic Surgery 
Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis  Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.
Different CABG methods in patients with chronic obstructive pulmonary disease  Mustafa Güler, MD, Kaan Kırali, MD, Mehmet E Toker, MD, Nilgün Bozbuğa,
Pulmonary function, postoperative pain, and serum cytokine level after lobectomy: a comparison of VATS and conventional procedure  Itaru Nagahiro, MD,
Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study  Robert J. Cerfolio, MD, Ayesha.
Pulmonary function after lobectomy: video-assisted thoracic surgery versus thoracotomy  Masao Nakata, MD, Hideyuki Saeki, MD, Nobuji Yokoyama, MD, Akira.
Lobectomy Versus Limited Resection in T1N0 Lung Cancer
Effects of minimal invasive coronary artery bypass on pulmonary function and postoperative pain  Artur Lichtenberg, MD, Christian Hagl, MD, Wolfgang Harringer,
Long-Term Results of Sleeve Lobectomy in the Management of Non–Small Cell Lung Carcinoma and Low-Grade Neoplasms  Robert E. Merritt, MD, Douglas J. Mathisen,
Short Operation Time: An Important Element to Reduce Operative Invasiveness in Pediatric Cardiac Surgery  Makoto Ando, MD, Yukihiro Takahashi, MD, Toshio.
Prognostic impact of large cell neuroendocrine histology in patients with pathologic stage Ia pulmonary non–small cell carcinoma  Akira Iyoda, MD, Kenzo.
Pulmonary Artery Leiomyosarcoma Expressing Epstein-Barr Virus in an Immunocompetent Individual  Sana Yokoi, MD, PhD, Toshihiko Iizasa, MD, PhD, Kenzo.
Presentation transcript:

Minimal alteration of pulmonary function after lobectomy in lung cancer patients with chronic obstructive pulmonary disease  Yasuo Sekine, MD, Takekazu Iwata, MD, Masako Chiyo, MD, Kazuhiro Yasufuku, MD, Shinichiro Motohashi, MD, Shigetoshi Yoshida, MD, Makoto Suzuki, MD, Toshihiko Iizasa, MD, Yukio Saitoh, MD, Takehiko Fujisawa, MD  The Annals of Thoracic Surgery  Volume 76, Issue 2, Pages 356-361 (August 2003) DOI: 10.1016/S0003-4975(03)00489-2

Fig 1 The ratio of actual postoperative forced expiratory volume in 1 second to predicted postoperative forced expiratory volume in 1 second (apo/ppo FEV1) was higher in the chronic obstructive pulmonary disease (COPD) group than that in the non-COPD group (p < 0.01). (Dotted line = apo/ppoFEV1 = 1.0.) The Annals of Thoracic Surgery 2003 76, 356-361DOI: (10.1016/S0003-4975(03)00489-2)

Fig 2 The correlation between actual postoperative forced expiratory volume in 1 second (apoFEV1) and modified predicted postoperative forced expiratory volume in 1 second calculated by the new equation. Modified predicted postoperative forced expiratory volume in 1 second (ppoFEV1) was significantly correlated with apoFEV1 (R2 = 0.619, p < 0.001). (Black diamonds = the value of the modified ppoFEV1 plotted against the apoFEV1 values.) The Annals of Thoracic Surgery 2003 76, 356-361DOI: (10.1016/S0003-4975(03)00489-2)